Latest read on rare disease gene therapy from Insmed CEO Will Lewis CNBC Television 9 months ago Play Download
Insmed CEO on what’s next for company after FDA greenlights lung disease drug CNBC Television 1 year ago Play Download
Insmed CEO Will Lewis talks its rare disease drug pipeline CNBC Television 7 months ago Play Download
The ‘Best in BioTech’!? Put this one on your watchlist! #biotechnology #stockstowatch #INSMED #INSM Market Maven 11 months ago Play Download
Insmed (INSM): The Revenue Beat Is Real. The Earnings Beat Is The Share Price. Charged Alpha Stock Encyclopedia 12 days ago Play Download
Insmed's ASCEND Study and INS1201, an Investigational Gene Therapy for Duchenne Muscular Dystrophy CureDuchenneMD 9 months ago Play Download
Insmed’s ASCEND Study and INS1201, an Investigational Gene Therapy for Duchenne Muscular Dystrophy MDA 7 months ago Play Download
